Profile: InterCure Ltd (INCR.TA)
INCR.TA on Tel Aviv Stock Exchange
Change (% chg)
InterCure Ltd is an Israel-based medical device company. It is engaged in the production and sale of RESPeRATE, a Food and Drug Administration approved, non-drug, non-invasive hypertension treatment device. The Company’s patented device-guided breathing platform is used by RESPeRATE, and it enables a systematic reduction in sympathetic outflow of the autonomous nervous system, one of the key underlining causes for cardiovascular disease, insomnia and multiple other conditions. The Company operates a marketing office in London and outsourced call centers and warehouses in the United States, the United Kingdom, Germany and Canada.